Related Experiment Video
Updated: Apr 5, 2026

08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
9.0K
Engineering Micromechanical Systems for the Next Generation Wireless Capsule Endoscopy.
Stephen Woods1, Timothy Constandinou1
1Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering and Institute of Biomedical Engineering, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK.
Biomed Research International
|August 11, 2015
Summary
Next-generation wireless capsule endoscopy (WCE) microrobots can now deliver targeted drug therapy in the small intestine. This innovation enhances WCE capabilities for diagnosing and treating gastrointestinal diseases.
Area of Science:
- Biomedical Engineering
- Gastroenterology
- Microrobotics
Background:
- Wireless capsule endoscopy (WCE) is crucial for diagnosing inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
- Current WCE devices lack therapeutic capabilities, necessitating conventional treatments for diagnosed pathologies.
- Targeted drug delivery in the small intestine remains a significant challenge in gastrointestinal treatment.
Purpose of the Study:
- To introduce a next-generation WCE with integrated targeted drug delivery functionality.
- To present a prototype microrobot capable of resisting peristaltic forces and delivering medication.
- To analyze the mechanics of a novel holding mechanism and micropositioning system for targeted therapy.
Main Methods:
- Fabrication of a Nylon 6 prototype microrobot with an integrated holding mechanism.
- Development of a micropositioning system utilizing a single micromotor for needle deployment.
- Mechanical analysis of the holding mechanism and review of microactuators and current WCE technology.
Main Results:
- The microrobot prototype successfully resists peristaltic pressure using an 'anchor' holding mechanism.
- The holding mechanism occupies a minimal volume (347.0 mm³) for an 11.0 mm diameter WCE.
- A micropositioning system enables radial positioning and deployment of a needle for targeted medication delivery (1 mL dose).
Conclusions:
- The developed microrobot demonstrates feasibility for targeted drug delivery within the small intestine.
- This novel functionality significantly enhances WCE capabilities beyond diagnosis to include treatment.
- Future WCE generations equipped with this technology could revolutionize GI tract pathology management.

